[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Forte Biosciences Inc (FBRX)

Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 704,436
  • Shares Outstanding, K 13,886
  • Annual Sales, $ 0 K
  • Annual Income, $ -69,380 K
  • EBIT $ -77 M
  • EBITDA $ -77 M
  • 60-Month Beta 2.85
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 15.66

Options Overview Details

View History
  • Implied Volatility 186.53% (+0.24%)
  • Historical Volatility 177.51%
  • IV Percentile 58%
  • IV Rank 46.89%
  • IV High 291.19% on 11/06/25
  • IV Low 94.11% on 07/28/25
  • Expected Move (DTE 30) 17.17 (30.32%)
  • Put/Call Vol Ratio 20.75
  • Today's Volume 87
  • Volume Avg (30-Day) 196
  • Put/Call OI Ratio 4.51
  • Today's Open Interest 1,283
  • Open Int (30-Day) 1,427
  • Expected Range 39.46 to 73.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-1.08
  • Number of Estimates 1
  • High Estimate $-1.08
  • Low Estimate $-1.08
  • Prior Year $-0.96
  • Growth Rate Est. (year over year) -12.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.89 +235.29%
on 06/23/26
56.84 -0.37%
on 07/22/26
+38.35 (+209.79%)
since 06/22/26
3-Month
15.51 +265.12%
on 06/08/26
56.84 -0.37%
on 07/22/26
+26.80 (+89.84%)
since 04/22/26
52-Week
9.10 +522.31%
on 08/06/25
56.84 -0.37%
on 07/22/26
+46.20 (+442.95%)
since 07/22/25

Most Recent Stories

More News
FB102 Achieves Statistically Significant Improvement in Vitiligo at Week 24 After Completion of 12-Week Treatment Period

Statistically Significant FB102 Benefit Observed By Day 64 and Continued through Week 24 FB102-Treated Subjects Continued Improving Through Week 24 After Completion of...

FBRX : 56.63 (+11.63%)
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the issuance...

FBRX : 56.63 (+11.63%)
Forte Biosciences, Inc. Announces First Quarter 2026 Results and Provides Update

FB102 Received Fast Track Designation in Celiac Disease

FBRX : 56.63 (+11.63%)
Forte Biosciences Announces Pricing of $150 Million Public Offering

Forte Biosciences, Inc. (Nasdaq: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced the pricing of a public offering of 5,709,936 shares...

FBRX : 56.63 (+11.63%)
Forte Biosciences Announces Proposed Public Offering

Forte Biosciences, Inc. (Nasdaq: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced that it has commenced an underwritten public offering...

FBRX : 56.63 (+11.63%)
Forte Biosciences, Inc. Announces 2025 Results and Provides Update

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced its full year...

FBRX : 56.63 (+11.63%)
Forte Biosciences Faces Critical Test as Losses Expected to Widen Sharply

Barchart Research What to Expect from FBRX Earnings FBRX Generated March 26, 2026 Current Price $27.01 EPS Estimate $-1.42 Consensus Rating Strong Buy Average Move 6.02% Forte Biosciences Faces Critical...

FBRX : 56.63 (+11.63%)
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on developing FB102, which is a proprietary anti-CD122 monoclonal antibody...

FBRX : 56.63 (+11.63%)
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on developing FB102, which is a proprietary anti-CD122 monoclonal antibody...

FBRX : 56.63 (+11.63%)
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings

Forte Biosciences, Inc. ( www.fortebiorx.com ) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced it will be...

FBRX : 56.63 (+11.63%)

Business Summary

Forte Biosciences Inc. is a clinical stage, dermatology company. It engages in developing biotherapeutic, FB-401, for the treatment of inflammatory skin diseases which is in clinical stage. Forte Biosciences Inc., formerly known as Tocagen Inc., is based in Sherman Oaks, California.

See More

Key Turning Points

3rd Resistance Point 67.73
2nd Resistance Point 62.29
1st Resistance Point 59.46
Last Price 56.63
1st Support Level 51.18
2nd Support Level 45.74
3rd Support Level 42.91

See More

52-Week High 56.84
Last Price 56.63
Fibonacci 61.8% 38.60
Fibonacci 50% 32.97
Fibonacci 38.2% 27.34
52-Week Low 9.10

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.